Outcome of Board Meeting

Morepen Laboratories' board approved Q1 FY27 consolidated financial results: revenue Rs 570.13 Cr, net profit Rs 56.35 Cr (EPS Rs 1.03). They set Sep 19, 2026, as record date for the FY26 dividend and extended the Medical Devices business hive-off timeline.

Mr. Sushil Suri's reappointment as CMD for three years is proposed.

AGM on Sep 26.